Oxycodone/naltrexone: Pilot trial data

An open-label, cross-over pilot trial in 16 healthy volunteers showed that all 3 doses of twice-daily ELI-201 were bioequivalent to an undisclosed reference drug based on pharmacokinetic measures, inc...